5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.

Meng CQ, Rakhit S, Lee DK, Kamboj R, McCallum KL, Mazzocco L, Dyne K, Slassi A.

Open source

DOI
10.1016/s0960-894x(00)00133-5
Published
2000-05-01
Container
Bioorg Med Chem Lett
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0960-894x-00-00133-5,
  title = {5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.},
  author = {Meng CQ and  Rakhit S and  Lee DK and  Kamboj R and  McCallum KL and  Mazzocco L and  Dyne K and  Slassi A.},
  year = {2000},
  journal = {Bioorg Med Chem Lett},
  doi = {10.1016/s0960-894x(00)00133-5},
  url = {https://doi.org/10.1016/s0960-894x(00)00133-5}
}

RIS

TY  - JOUR
TI  - 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.
AU  - Meng CQ
AU  -  Rakhit S
AU  -  Lee DK
AU  -  Kamboj R
AU  -  McCallum KL
AU  -  Mazzocco L
AU  -  Dyne K
AU  -  Slassi A.
PY  - 2000
JO  - Bioorg Med Chem Lett
DO  - 10.1016/s0960-894x(00)00133-5
UR  - https://doi.org/10.1016/s0960-894x(00)00133-5
ER  - 

APA

CQ, M., S, R., DK, L., R, K., KL, M., L, M., K, D., & A., S. (2000). 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.. Bioorg Med Chem Lett. https://doi.org/10.1016/s0960-894x(00)00133-5

Source records